SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-288225
Filing Date
2013-07-11
Accepted
2013-07-11 17:01:12
Documents
3
Period of Report
2013-07-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d567187d8k.htm 8-K 14794
2 EX-99.1 d567187dex991.htm EX-99.1 4428
3 GRAPHIC g567187g47h82.jpg GRAPHIC 3847
  Complete submission text file 0001193125-13-288225.txt   26097
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 13964365
SIC: 2834 Pharmaceutical Preparations